Silvia Tyčiaková

CRISPR/Cas9-edited organoids as a platform for tailored research of colorectal cancer

Colorectal cancer is one of the most commonly diagnosed cancers worldwide. Mortality rates and limited therapeutic options justify the development of reliable preclinical research models, as their translational value remains limited. Simple in vitro models do not recapitulate tum...